Brown bagging in pharmacy is when a specialty pharmacy dispenses a medication directly to a patient, who then physically carries it to their doctor’s office or clinic for administration. The term evokes the image of a patient walking in with a brown bag containing their own medication, often an injectable or infusion drug that must be given by a healthcare professional.
How Brown Bagging Works
In a traditional setup, your doctor’s office buys specialty medications in bulk, stores them properly, and administers them to you during your appointment. The practice bills your insurance for both the drug and the administration. This is called the “buy and bill” model, and it’s been the standard for decades.
Brown bagging disrupts that chain. Instead, your insurance company or pharmacy benefit manager (PBM) routes the prescription to a designated specialty pharmacy. That pharmacy fills the prescription and ships it to your home or has you pick it up. You then bring the medication with you to your next appointment, where your provider administers it. The clinic gets reimbursed only for the administration, not the drug itself.
Why Insurance Companies Favor It
The financial logic is straightforward. When a hospital or clinic buys a drug and bills insurance, it typically adds a markup to cover handling, storage, and waste. By routing the drug through a specialty pharmacy it contracts with, the insurer eliminates that provider markup entirely. The common thread across all “bagging” policies is replacing buy and bill with a model where the clinician receives the drug from another entity and is paid only for giving the injection or infusion.
Insurers and PBMs have been increasingly requiring these arrangements, particularly as specialty drug spending has grown. For a biologic infusion that costs thousands of dollars per dose, even a modest percentage markup represents significant money.
Which Medications Are Involved
Brown bagging overwhelmingly involves specialty drugs, the high-cost medications used for serious or chronic conditions. According to the Academy of Managed Care Pharmacy, the most common medications in brown bagging programs include injectable chemotherapy drugs and chemotherapy support medications, biologics used to treat rheumatoid arthritis and Crohn’s disease, blood clotting factors, immune globulins, and certain vaccines. These are drugs that patients cannot simply swallow at home. They require IV infusion, injection, or clinical monitoring during administration.
Brown Bagging vs. White Bagging vs. Clear Bagging
These three terms describe variations on the same idea, with the key difference being where the drug gets delivered:
- Brown bagging: The specialty pharmacy sends the drug to the patient, who transports it to the provider’s office.
- White bagging: The specialty pharmacy ships the drug directly to the provider’s office or hospital, bypassing the patient entirely.
- Clear bagging: A hospital uses its own internal specialty pharmacy to fill the prescription and transport it to the site of administration within the same facility.
Of the three, brown bagging places the most responsibility on the patient. White bagging at least keeps the drug in a professional supply chain from pharmacy to clinic. Clear bagging is closest to the traditional model since the hospital retains control throughout.
Safety Concerns With Brown Bagging
This is where the practice gets controversial. Many of the drugs involved in brown bagging are biologics or chemotherapy agents that require strict temperature control, often continuous refrigeration. When a patient picks up the drug and drives it to an appointment, there’s a gap in what’s called the “cold chain,” the unbroken series of refrigerated storage and transport that keeps temperature-sensitive drugs effective and safe.
Consider what can go wrong. A patient picks up an infusion drug from the pharmacy, puts it in their car on a warm day, runs an errand, and arrives at the clinic 90 minutes later. The clinic has no way to verify that the medication was stored at the right temperature during that time. It also can’t confirm the drug wasn’t tampered with, contaminated, or damaged. For a chemotherapy drug or immune globulin, these aren’t hypothetical risks.
There’s also a coordination problem. If your dose changes between when the prescription was filled and your appointment, the drug you’re carrying may no longer be correct. In a buy-and-bill model, the provider adjusts the dose in real time from their own supply. With brown bagging, a dose change can mean wasted medication and a delayed treatment.
Where Pharmacy Organizations Stand
The American Society of Health-System Pharmacists has taken a firm position: brown bagging and white bagging undermine hospitals’ patient safety protections and jeopardize patient care. The organization argues these practices let insurers, rather than your pharmacist and healthcare provider, dictate when, where, and how drugs are purchased, prepared, and administered. ASHP has pushed for state lawmakers to prohibit insurers and PBMs from mandating brown bagging or penalizing health systems that refuse to accept these medications.
The core concern from providers is simple. When a patient walks in carrying their own specialty drug, the clinic is being asked to administer a medication it cannot confirm was stored and prepared safely. That creates a liability and safety gap that didn’t exist under the traditional model.
What This Means for Patients
If your insurer requires brown bagging for your medication, you become a link in the pharmaceutical supply chain. That means you’re responsible for picking up the drug on time, storing it correctly at home (often in the refrigerator, away from food, at a specific temperature range), transporting it to your appointment without breaking the cold chain, and coordinating the timing so the drug arrives before its expiration or beyond-use date.
Some patients find brown bagging convenient if they already use a specialty pharmacy for other prescriptions. But for many, especially those managing cancer treatment or autoimmune conditions, it adds logistical stress to an already demanding routine. If the drug arrives damaged or at the wrong dose, your treatment may be delayed while a replacement is ordered.
The regulatory landscape is still catching up. Some states have begun introducing legislation to limit mandatory bagging policies, but rules vary widely. If you’re told your medication will now go through a brown bagging arrangement, it’s worth asking your provider’s office how they handle verification of drug integrity and what happens if there’s a problem with the medication you bring in.